How CogniMary is supposed to work
Every supplement has a story about why it should work. This page separates the story from the evidence, ingredient family by ingredient family.
CogniMary's formula groups into four rough mechanisms: blood flow (ginkgo, bilberry), neurotransmitter and membrane support (GPC choline, L-theanine), antioxidant and metabolic support (alpha lipoic acid, green tea, berberine, cinnamon, chromium), and basic nutrient cofactors (folate, B12, magnesium).
Each story is plausible. The evidence that any of them changes cognition in a healthy adult is weak, and the amounts available inside a 635 mg blend are mostly below the amounts the research used.
The four stories this formula tells
Nothing on the CogniMary label states a mechanism. The ingredient list implies four, and they are the four that most formulas in this category are built from.
Blood flow to the brain
Ginkgo and bilberry are both associated with vascular effects. The reasoning is that better perfusion means better function.
Ginkgo, bilberry
Membranes and messengers
GPC choline supplies choline for acetylcholine and for cell membranes. L-theanine influences alpha-wave activity and is associated with calm attention.
GPC choline, L-theanine
Oxidative and metabolic support
Alpha lipoic acid, green tea catechins, berberine, cinnamon and chromium all touch oxidative stress or glucose handling. The reasoning is that a brain runs on glucose and dislikes oxidative damage.
ALA, green tea, berberine, cinnamon, chromium
Nutrient cofactors
Folate, B12 and magnesium are genuinely required for nervous-system function. The reasoning is that topping them up helps.
Folate, B12, magnesium
All four stories are biologically coherent. None of them is the same thing as a demonstrated effect in a person who is not deficient or ill, and that distinction is where most of this category goes wrong.
Where each story runs out
| Mechanism | Strongest evidence | Where it stops |
|---|---|---|
| Blood flow | Ginkgo has decades of trials and a large NIH-funded study | That study, GEM, found no effect on cognitive decline at 240 mg a day |
| Membranes and messengers | One 2024 randomised trial of 600 mg GPC choline in amnestic MCI was positive | Single trial, in a diagnosed population, at roughly nine times the ceiling here |
| Attention and calm | A 200 mg dose of L-theanine improved visual attention | Only in high trait-anxiety participants, acutely, at over twice the ceiling here |
| Oxidative support | Alpha lipoic acid has a real record in nerve pain | Cochrane found no randomised trials at all of ALA for dementia |
| Glucose handling | Berberine and cinnamon both move glycaemic markers | Neither has human cognition evidence; berberine has none at all |
| Nutrient cofactors | Deficiency in folate or B12 genuinely impairs neurological function | In people who are not deficient, the reviews find no cognitive benefit |
Scroll this table sideways →
The honest summary is that this formula is assembled from ingredients with real literature, and that the literature mostly points at populations, doses or outcomes that are not the ones on the front of this bottle.
The deficiency question
There is one route by which a product like this can make a real difference, and it deserves to be stated properly rather than buried.
If you are genuinely deficient in vitamin B12 or folate, the consequences include neurological ones, and correcting the deficiency matters a great deal. Deficiency is not rare — it is more common with age, with certain medications, and on diets that exclude animal products.
But the route runs through a blood test, not a product page
If you suspect a deficiency, the useful next step is a clinician and a blood test, not a supplement bought on the strength of a marketing claim. A test tells you whether you need anything and how much. A capsule with a hundred times the reference intake in it does not.
The distinction matters because “this nutrient is essential for brain function” is true of many nutrients and is not a reason to take extra of them. Water is essential too.
What the combination argument is worth
The strongest defence of a formula like this is that the combination does something the parts do not. It is worth taking seriously for a moment, and then looking at what would be needed to believe it.
- It is possible. Combinations can behave differently from their components, and nutrition science has real examples.
- It is also unfalsifiable as usually stated. Without a trial of the combination, “it works together” cannot be checked by anyone.
- No trial of this combination exists. We looked. There is no published study of the WMG-NVT blend, and there would be no way to run one without the split.
- The argument cuts both ways. If combination effects are real enough to create benefit at low doses, they are real enough to create interactions at low doses too.
Our position is that synergy is a reason to run a trial, not a reason to skip one.
What would change our reading
- The split, published. If GPC choline turned out to be at 600 mg, this page would say something different about it — though 600 mg cannot fit at position nine.
- A trial of the finished product, however small, with a control group.
- Extract ratios for the botanicals, so a low weight of a concentrated extract could be assessed properly.
- A replication of the 2024 GPC choline result in a healthy population.
None of these is unreasonable and none of them exists today. Until they do, the fair description of this formula is a reasonable-looking ingredient list whose amounts cannot be checked.
Order CogniMary from the official website
Sixty capsules, thirty days, and a panel you can read before you buy. Start with one bottle so you can see the price and the guarantee term before you commit to six.
No price was published to this website. The figure is on the checkout page.
References
The sources behind the numbers on this page.
- Snitz, O'Meara, Carlson et al. — 2009Ginkgo biloba for Preventing Cognitive Decline in Older Adults: A Randomized Trial — JAMA · PMID 20040554 · source
- Birks & Grimley Evans — 2009Ginkgo biloba for cognitive impairment and dementia — Cochrane Database of Systematic Reviews · CD003120.pub3 · source
- Lee, Kim, Park et al. — 2024Efficacy and safety of choline alphoscerate for amnestic mild cognitive impairment: a randomized double-blind placebo-controlled trial — BMC Geriatrics · PMID 39300341 · source
- Higashiyama, Htay, Ozeki et al. — 2011Effects of l-theanine on attention and reaction time response — Journal of Functional Foods · DOI 10.1016/j.jff.2011.03.009 · source
- Klugman, Sauer, Tabet & Howard — 2004Alpha lipoic acid for dementia — Cochrane Database of Systematic Reviews · CD004244.pub2 · source
- Alzheimer's Drug Discovery FoundationBerberine — Cognitive Vitality For Researchers — alzdiscovery.org · source
- Ranasinghe et al. — 2025Effects of Cinnamomum zeylanicum extract on lipid profile, glucose levels and its safety in adults: a randomized, double-blind, controlled trial — PLOS ONE · DOI 10.1371/journal.pone.0317904 · source
- Malouf, Grimley Evans & Areosa Sastre — 2003Folic acid with or without vitamin B12 for cognition and dementia — Cochrane Database of Systematic Reviews · CD004514 · source
- Markun, Gravestock, Jäger et al. — 2021Effects of Vitamin B12 Supplementation on Cognitive Function, Depressive Symptoms, and Fatigue: A Systematic Review, Meta-Analysis, and Meta-Regression — Nutrients · DOI 10.3390/nu13030923 · source
- Chen et al. — 2024Magnesium and Cognitive Health in Adults: A Systematic Review and Meta-Analysis — Advances in Nutrition · PMC11362647 · source
- Chew, Clemons, Agrón et al. — 2015Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial — JAMA · PMID 26305649 · source
The placebo question, taken seriously
In a category where the outcome is subjective, expectation does real work, and it is not a reason to be dismissive.
Placebo effects are real effects
People genuinely feel better. In subjective outcomes the effect can be substantial, and it is the reason trials are blinded and controlled.
Not imaginary
They are also why trials exist
A trial asks whether the capsule beats the expectation. When GEM and AREDS2 found nothing, both arms had the expectation; only one had the ingredient.
The comparison is the point
The behaviour around it matters too
Deciding to take your cognition seriously often comes with earlier nights and more exercise. Those are the interventions with the evidence, and the capsule gets the credit.
The confound nobody controls for
Which is why one variable at a time
If you change three things and feel better, you have learned nothing about any of them. The timeline page is built around this.
The practical response
None of this says the product does nothing. It says that feeling better is not by itself evidence that the capsule did it, and that a fair test has to be designed rather than felt.
What would make us change this page
- A randomised controlled trial of this finished formula.
- The blend split published, showing amounts at or near the researched doses.
- Extract ratios that make a low weight of a concentrated extract equivalent to a trial dose.
- A replication of the 2024 GPC choline result in people without a diagnosis.
Writing down what would change our mind is the cheapest honesty available, and it is rare enough in this category to be worth doing explicitly.